Cargando…

Rheumatoid arthritis treatment with TNF inhibitors and alternative procedures in case of its failure – results of the Polish survey in the context of EULAR recommendations

INTRODUCTION: According to the European League Against Rheumatism (EULAR), rheumatoid arthritis (RA) treatment aims to achieve remission or low disease activity (LDA) within 6 months. In Poland, despite the existence of the National Health Fund Drug Program (NHF-DP), data on the effects of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tłustochowicz, Małgorzata, Dębowska, Grażyna, Spytek, Joanna, Tłustochowicz, Witold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847287/ https://www.ncbi.nlm.nih.gov/pubmed/27407248 http://dx.doi.org/10.5114/reum.2015.53997

Ejemplares similares

Prevalence of Atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis
por: Kisiel, Bartłomiej, et al.
Publicado: (2015)

A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients
por: Kur-Zalewska, Joanna, et al.
Publicado: (2021)

Early Myocardial Changes in Patients with Rheumatoid Arthritis without Known Cardiovascular Diseases—A Comprehensive Cardiac Magnetic Resonance Study
por: Malczuk, Ewa, et al.
Publicado: (2021)

Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis
por: Raczkiewicz, Anna, et al.
Publicado: (2016)

Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis
por: Kisiel, Bartłomiej, et al.
Publicado: (2015)

Trends in psoriatic arthritis epidemiology in Poland
por: Tłustochowicz, Małgorzata, et al.
Publicado: (2020)

Sequentiality of treatment in the rheumatoid arthritis drug programme in the years 2009–2014
por: Tłustochowicz, Małgorzata, et al.
Publicado: (2016)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

Age, Cognitive Factors, and Acceptance of Living with the Disease in Rheumatoid Arthritis: The Short-Term Perspective
por: Pankowski, Daniel, et al.
Publicado: (2022)

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries
por: Orlewska, Ewa, et al.
Publicado: (2011)

Changes in the morbidity and costs of systemic lupus erythematosus in Poland in the years 2008–2012
por: Śliwczyński, Andrzej, et al.
Publicado: (2015)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
por: Smolen, Josef S, et al.
Publicado: (2010)

EULAR definition of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2021)

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
por: Gerlag, Danielle M, et al.
Publicado: (2012)

Etanercept treatment in juvenile idiopathic arthritis: The Polish registry
por: Żuber, Zbigniew, et al.
Publicado: (2011)

Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system – the case of Poland
por: Raciborski, Filip, et al.
Publicado: (2016)

Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
por: Kerschbaumer, Andreas, et al.
Publicado: (2020)

DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
por: Navarro-Sarabia, Federico, et al.
Publicado: (2009)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
por: Smolen, Josef S, et al.
Publicado: (2014)

Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
por: Roodenrijs, Nadia M T, et al.
Publicado: (2021)

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
por: Gossec, Laure, et al.
Publicado: (2020)

The Impact of Vitamin D Supplementation on Vitamin D Level, Urinary Calcium Excretion and Bone Density in Patients with Hypercalciuria and Vitamin D Deficiency − Preliminary Report
por: Milart, Joanna, et al.
Publicado: (2018)

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
por: Michelsen, Brigitte, et al.
Publicado: (2023)

Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
por: Roodenrijs, Nadia M T, et al.
Publicado: (2021)

Correction: EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Publicado: (2020)

2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
por: Nikiphorou, Elena, et al.
Publicado: (2021)

EULAR recommendations for intra-articular therapies
por: Uson, Jacqueline, et al.
Publicado: (2021)

American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision
por: Studenic, Paul, et al.
Publicado: (2023)

American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision
por: Studenic, Paul, et al.
Publicado: (2022)

The Features of the Synovium in Early Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria
por: van de Sande, Marleen G. H., et al.
Publicado: (2012)

EULAR Task Force Recommendations on Annual Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis: An Audit of the Success of Implementation in a Rheumatology Outpatient Clinic
por: Ikdahl, Eirik, et al.
Publicado: (2015)

Validation of ACR/EULAR definition of remission in rheumatoid arthritis from RA practice: the ESPOIR cohort
por: Zhang, Bin, et al.
Publicado: (2012)

The Role of Bone Scintigraphy in the Diagnosis of Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria
por: Kim, Ji Young, et al.
Publicado: (2014)

Utility of the new rheumatoid arthritis 2010 ACR/EULAR classification criteria in routine clinical care
por: Kennish, Lauren, et al.
Publicado: (2012)

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH)
por: Alves, Celina, et al.
Publicado: (2011)

Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project
por: van Beers-Tas, Marian H, et al.
Publicado: (2018)

Effects of exercise and physical activity promotion: meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip/knee osteoarthritis
por: Rausch Osthoff, Anne-Kathrin, et al.
Publicado: (2018)

Therapeutic monitoring of TNF inhibitors for rheumatoid arthritis: evidence required following NICE’s recommendations
por: Gavan, Sean P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_knrivrquo5t7eg9h4v1hn7ekmi